Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
Scientific Reports
|
October 20, 2015
Targeting autocrine HB-EGF signaling with specific ADAM12 inhibition using recombinant ADAM12 prodomain
Miles A Miller, Marcia L Moss, Gary Powell, et al.
The Journal of Biological Chemistry
|
April 2, 2011
Species specificity of ADAM10 and ADAM17 proteins in interleukin-6 (IL-6) trans-signaling and novel role of ADAM10 in inducible IL-6 receptor shedding
Christoph Garbers, Nathalie Jänner, Athena Chalaris, et al.
Journal of Cancer
|
January 17, 2020
Development of flow cytometry assays for measuring cell-membrane enzyme activity on individual cells
Michael Gorry, Toshie Yoneyama, Lazar Vujanovic, et al.
The Journal of Biological Chemistry
|
March 29, 2007
The low affinity IgE receptor (CD23) is cleaved by the metalloproteinase ADAM10
George A Lemieux, Fernando Blumenkron, Nolan Yeung, et al.
The Journal of Biological Chemistry
|
September 27, 2007
The ADAM10 prodomain is a specific inhibitor of ADAM10 proteolytic activity and inhibits cellular shedding events
Marcia L Moss, Martha Bomar, Qian Liu, et al.
Journal of Leukocyte Biology
|
October 16, 2002
Endotoxin induces rapid metalloproteinase-mediated shedding followed by up-regulation of the monocyte hemoglobin scavenger receptor CD163
Katharine A Hintz, Athos J Rassias, Kathleen Wardwell, et al.
Biochemistry
|
July 24, 2002
The tumor necrosis factor-alpha converting enzyme (TACE): a unique metalloproteinase with highly defined substrate selectivity
Mohita J Mohan, Theresa Seaton, Justin Mitchell, et al.
Journal of Cancer
|
December 1, 2017
Modification of proteolytic activity matrix analysis (PrAMA) to measure ADAM10 and ADAM17 sheddase activities in cell and tissue lysates
Toshie Yoneyama, Michael Gorry, Miles A Miller, et al.
Journal of Cancer
|
July 21, 2018
ADAM10 Sheddase Activity is a Potential Lung-Cancer Biomarker
Toshie Yoneyama, Michael Gorry, Andrea Sobo-Vujanovic, et al.
British Journal of Pharmacology
|
October 9, 2025
Leveraging the ADAM10 prodomain for selective inhibition to enhance recovery after myocardial infarction
Erik Klapproth, Johanna Marks, Patrick Diaba-Nuhoho, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
Scientific Reports
|
October 20, 2015
Targeting autocrine HB-EGF signaling with specific ADAM12 inhibition using recombinant ADAM12 prodomain
Miles A Miller, Marcia L Moss, Gary Powell, et al.
The Journal of Biological Chemistry
|
April 2, 2011
Species specificity of ADAM10 and ADAM17 proteins in interleukin-6 (IL-6) trans-signaling and novel role of ADAM10 in inducible IL-6 receptor shedding
Christoph Garbers, Nathalie Jänner, Athena Chalaris, et al.
Journal of Cancer
|
January 17, 2020
Development of flow cytometry assays for measuring cell-membrane enzyme activity on individual cells
Michael Gorry, Toshie Yoneyama, Lazar Vujanovic, et al.
The Journal of Biological Chemistry
|
March 29, 2007
The low affinity IgE receptor (CD23) is cleaved by the metalloproteinase ADAM10
George A Lemieux, Fernando Blumenkron, Nolan Yeung, et al.
The Journal of Biological Chemistry
|
September 27, 2007
The ADAM10 prodomain is a specific inhibitor of ADAM10 proteolytic activity and inhibits cellular shedding events
Marcia L Moss, Martha Bomar, Qian Liu, et al.
Journal of Leukocyte Biology
|
October 16, 2002
Endotoxin induces rapid metalloproteinase-mediated shedding followed by up-regulation of the monocyte hemoglobin scavenger receptor CD163
Katharine A Hintz, Athos J Rassias, Kathleen Wardwell, et al.
Biochemistry
|
July 24, 2002
The tumor necrosis factor-alpha converting enzyme (TACE): a unique metalloproteinase with highly defined substrate selectivity
Mohita J Mohan, Theresa Seaton, Justin Mitchell, et al.
Journal of Cancer
|
December 1, 2017
Modification of proteolytic activity matrix analysis (PrAMA) to measure ADAM10 and ADAM17 sheddase activities in cell and tissue lysates
Toshie Yoneyama, Michael Gorry, Miles A Miller, et al.
Journal of Cancer
|
July 21, 2018
ADAM10 Sheddase Activity is a Potential Lung-Cancer Biomarker
Toshie Yoneyama, Michael Gorry, Andrea Sobo-Vujanovic, et al.
British Journal of Pharmacology
|
October 9, 2025
Leveraging the ADAM10 prodomain for selective inhibition to enhance recovery after myocardial infarction
Erik Klapproth, Johanna Marks, Patrick Diaba-Nuhoho, et al.
Page
of 4